SCHEMBL6539792

SCHEMBL6539792

CCCNC(=O)c1ccc(C(=O)Nc2ccc(C[C@@H](CO)N(Cc3ccccc3)C[C@H](O)COc3ccccc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 10/20 0.53
ADRB3 P13945 10/20 0.53
ADRB2 P07550 4/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 3/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538732 0.91 ADRB1 (0.50) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6538563 0.91 ADRB1 (0.54) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6540060 0.91 ADRB1 (0.48) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6539381 0.90 ADRB1 (0.54) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6538889 0.90 ADRB1 (0.49) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6538485 0.89 ADRB1 (0.47) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6538663 0.89 ADRB1 (0.48) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6538597 0.86 NR1H4 (0.48) ADRB1ADRB3ADRB2MEN1KMT2A
SCHEMBL6539510 0.86 ADRB1 (0.59) ADRB1ADRB3ADRB2MAPT
SCHEMBL6539617 0.85 ADRB1 (0.57) ADRB1ADRB3ADRB2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed